Company intelligence / Profile preview

Corundum Systems Biology

Shibuya-ku, Tokyo, Japancsb.co.jp ↗

Ownership: Private
Development stage: Other

Overview

Corundum Systems Biology is an active Japanese investment firm focused on advancing human health through systems biology and multiomics approaches. It provides funding, resources, mentorship, and access to unique health data to support the commercialization of research discoveries. The company has invested in at least three Boston-based biotech startups working on microbiome science and precision medicine solutions.

Therapeutic areas: PsychiatryNeurology
Modalities: ProbioticMicrobial therapySmall molecule
Industry: Investors

Partnerships

HolobiomeAcademic institutions focused on microbiome/systems biology researchBiotech startups focused on microbiome/systems biology research

Beyond the preview

Go deeper on Corundum Systems Biology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corundum Systems Biology.

Explore the full profile